problems with ATRA therapy
Last reviewed 01/2018
There are some problems with ATRA therapy:
- the remission is short-lived and ATRA does not work the second time (inducible cytoplasmic molecules mop it up)
- 25% of patients develop the ATRA syndrome
- side-effects, although trivial when compared to those of cytotoxic therapy, are numerous